The B-cell epitope of the monoclonal anti-factor VIII antibody ESH8 characterized by peptide array analysis

Thilo Albert; Christian Egler; Stanislav Jakuschev; Ulrike Schuldenzucker; Alexandra Schmitt; Olive Brokemper; Martin Zabe-Kühn; Daniel Hoffmann; Johannes Oldenburg; Rainer Schwaab

doi:10.1160/TH07-06-0400

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 99(03): 634-637
DOI: 10.1160/TH07-06-0400

Letters to the Editor

Schattauer GmbH

The B-cell epitope of the monoclonal anti-factor VIII antibody ESH8 characterized by peptide array analysis

Authors

Thilo Albert

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany
Christian Egler

²Center of advanced European studies and research, Bonn, Germany
Stanislav Jakuschev

³Department of Bioinformatics, Center for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany
Ulrike Schuldenzucker

²Center of advanced European studies and research, Bonn, Germany
Alexandra Schmitt

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany
Olive Brokemper

²Center of advanced European studies and research, Bonn, Germany
Martin Zabe-Kühn^*

²Center of advanced European studies and research, Bonn, Germany
Daniel Hoffmann

³Department of Bioinformatics, Center for Medical Biotechnology, University of Duisburg-Essen, Essen, Germany

²Center of advanced European studies and research, Bonn, Germany
Johannes Oldenburg

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany
Rainer Schwaab

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinics Bonn, Bonn, Germany

Abstract

Full Text

References

References
1 Griffin BD, Micklem LR, McCann MC. et al. The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIII. Thromb Haemost 1986; 55: 40-46.
2 Scandella D, Gilbert GE, Shima M. et al. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. Blood 1995; 86: 1811-1819.
3 Peerlinck K, Jacquemin MG, Arnout J. et al. Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A. Blood 1999; 93: 2267-2273.
4 Saenko EL, Shima M, Gilbert GE. et al. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition. J Biol Chem 1996; 271: 27424-27431.
5 Nogami K, Shima M, Hosokawa K. et al. Role of factor VIII C2 domain in factor VIII binding to factor Xa. J Biol Chem 1999; 274: 31000-31007.
6 Ahmad SS, Walsh PN. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane. Biochemistry 2005; 44: 13858-13865.
7 Saenko EL, Scandella D, Yakhyaev AV. et al. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets. J Biol Chem 1998; 273: 27918-27926.
8 Villard S, Piquer D, Raut S. et al. Low molecular weight peptides restore the procoagulant activity of factor VIII in the presence of the potent inhibitor antibody ESH8. J Biol Chem 2002; 277: 27232-27239.
9 Pratt KP, Shen BW, Takeshima K. et al. Structure of the C2 domain of human factor VIII at 1.5 A resolution. Nature 1999; 402: 439-442.
10 Spiegel PC, Jr Jacquemin M, Saint-Remy JM. et al. Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII. Blood 2001; 98: 13-19.
11 Myszka DG. Improving biosensor analysis. J Mol Recogn 1999; 12: 279-284.
12 Kopecky E-M, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays. J Immunol Methods 2006; 308: 90-100.